Medicaid health homes for sickle cell care

Summary#

The Sickle Cell Disease Comprehensive Care Act would amend title XIX of the Social Security Act, which governs Medicaid. Its goal is to let states offer Medicaid “health home” services focused mainly on eligible people with sickle cell disease; it would not require every state to do so. The bill has not become law.

  • Starting January 1, 2026, the Health and Human Services Secretary could approve a state plan amendment for a health home focused mainly on eligible people with sickle cell disease.
  • A state with an approved plan would have to provide dental and vision services to people with sickle cell disease enrolled in that health home, even if the state does not provide those services to other Medicaid beneficiaries.
  • After the plan has been in effect for eight fiscal-year quarters, the state would have to report on participants’ care quality, access to care, and total health-care expenditures. The Secretary would set the measures for those reports.
  • By June 30, 2026, the Secretary would have to publish best practices for these plans, based on clinical guidelines and developed in consultation with providers and patient advocacy organizations.
  • The bill also changes a Medicaid payment provision, but the supplied materials do not include the current text of that provision, so its effect cannot be verified.

What it means for you#

  • People with sickle cell disease on Medicaid: If your state has an approved plan and you enroll in its health home, the state would have to provide you dental and vision services. The bill does not guarantee that your state will create a plan or that you will automatically be enrolled.
  • Other Medicaid beneficiaries: The bill does not directly change your eligibility or benefits.
  • States: A state could seek approval for a plan focused mainly on eligible people with sickle cell disease. If approved, it would have to provide dental and vision services to enrolled participants and report on care quality, access, and expenditures.
  • Federal officials: The Secretary could approve these plans, must set reporting measures, and must publish best practices by the stated deadline.
  • Taxpayers: The bill does not set out an appropriation or a cost estimate.

Money#

No cost information is in the supplied material.

  • The bill would require participating states to provide dental and vision services to enrolled participants, but it gives no cost estimate.
  • States would have to report participants’ total health-care expenditures. The bill does not say that this reporting would reduce those expenditures.
  • The bill changes a Medicaid payment provision, but without the existing text of that provision, the payment effect is unclear.
  • The bill contains no explicit appropriation.

What is unclear#

  • States are not required to seek approval, so the bill does not ensure that health homes will be available in every state.
  • The bill does not spell out what services a health home must provide or how people would enroll.
  • It does not explain how participating states would pay for the required dental and vision services.
  • The bill defines eligible people as those eligible for Medicaid under a state plan or waiver who have sickle cell disease identified by newborn screening or another genetic test. It does not explain how eligibility would be confirmed in practice.
  • The supplied material does not include the current Medicaid law being amended, so the effect of the change to the payment provision could not be verified.

Case for#

  • The bill appears intended to make coordinated outpatient care available through health homes for people with sickle cell disease.
  • Requiring dental and vision services for enrolled participants could address gaps in care, even in states that do not provide those services to other Medicaid beneficiaries.
  • State reports on care quality, access, and expenditures could help show how the plans are working.
  • Federal best practices could give states guidance based on clinical guidelines and input from providers and patient advocacy organizations.

Case against#

  • Because states would not have to adopt a plan, access to this focused care could depend on where a person lives.
  • The bill requires dental and vision services for participants but does not provide a cost estimate or explain how states would pay for them.
  • The bill does not specify the health-home services, enrollment process, or other rules that would determine what care a participant actually receives.
  • The bill changes a payment provision without including enough current-law text to show the financial effect.